Immunosuppressive Agents

"Immunosuppressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.

Descriptor ID	D007166
MeSH Number(s)	D27.505.696.477.656
Concept/Terms	Immunosuppressive Agents Immunosuppressive Agents Agents, Immunosuppressive Immunosuppressants

Below are MeSH descriptors whose meaning is more general than "Immunosuppressive Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Immunologic Factors [D27.505.696.477]
Immunosuppressive Agents [D27.505.696.477.656]

Below are MeSH descriptors whose meaning is related to "Immunosuppressive Agents".

Below are MeSH descriptors whose meaning is more specific than "Immunosuppressive Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunosuppressive Agents" by people in this website by year, and whether "Immunosuppressive Agents" was a major or minor topic of these publications.

Bar chart showing 178 publications over 29 distinct years, with a maximum of 16 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1995	1	0	1
1996	1	0	1
1997	2	2	4
1998	2	1	3
1999	4	4	8
2000	2	2	4
2001	2	3	5
2002	4	6	10
2003	6	7	13
2004	2	6	8
2005	7	1	8
2006	0	3	3
2007	3	4	7
2008	4	2	6
2009	6	5	11
2010	2	3	5
2011	4	3	7
2012	4	4	8
2013	2	3	5
2014	6	2	8
2015	7	9	16
2016	6	4	10
2017	4	7	11
2018	3	3	6
2019	1	0	1
2020	2	2	4
2021	1	2	3
2022	0	1	1

Below are the most recent publications written about "Immunosuppressive Agents" by people in Profiles.

Fatima S, Abbas T, Refat MA, Harris JE, Lim HW, Hamzavi IH, Mohammad TF. Systemic therapies in vitiligo: a review. Int J Dermatol. 2023 Mar; 62(3):279-289.

View in: PubMed
Janardhana P, Al-Kadhi S. A review of ophthalmic manifestations of inflammatory bowel disease and associated treatments. Curr Opin Ophthalmol. 2021 Nov 01; 32(6):549-554.

View in: PubMed
Tomkins-Tinch CH, Daly JS, Gladden-Young A, Theodoropoulos NM, Madaio MP, Yu N, Vanguri VK, Siddle KJ, Adams G, Krasilnikova LA, Movahedi B, Bozorgzadeh A, Simin K, Lemieux JE, Luban J, Park DJ, MacInnis BL, Sabeti PC, Levitz SM. SARS-CoV-2 Reinfection in a Liver Transplant Recipient. Ann Intern Med. 2021 08; 174(8):1178-1180.

View in: PubMed
Jackson KR, Long J, Motter J, Bowring MG, Chen J, Waldram MM, Orandi BJ, Montgomery RA, Stegall MD, Jordan SC, Benedetti E, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Verbesey JE, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Wellen J, Bozorgzadeh A, Gaber AO, Heher E, Weng FL, Djamali A, Helderman JH, Concepcion BP, Brayman KL, Oberholzer J, Kozlowski T, Covarrubias K, Desai N, Massie AB, Segev DL, Garonzik-Wang J. Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes. Transplantation. 2021 02 01; 105(2):436-442.

View in: PubMed
Roedl K, Heidenreich S, Pfefferle S, Jarczak D, Urbanowicz TT, N?rz D, Aepfelbacher M, Kr?ger N, Kluge S, L?tgehetmann M, Christopeit M, Wichmann D. Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19. Am J Respir Crit Care Med. 2021 01 15; 203(2):242-245.

View in: PubMed
Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3. Arthritis Rheumatol. 2021 02; 73(2):e1-e12.

View in: PubMed
Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1. Arthritis Rheumatol. 2020 08; 72(8):1241-1251.

View in: PubMed
Maghzi AH, Houtchens MK, Preziosa P, Ionete C, Beretich BD, Stankiewicz JM, Tauhid S, Cabot A, Berriosmorales I, Schwartz THW, Sloane JA, Freedman MS, Filippi M, Weiner HL, Bakshi R. COVID-19 in teriflunomide-treated patients with multiple sclerosis. J Neurol. 2020 Oct; 267(10):2790-2796.

View in: PubMed
Yao CG, Martins PN. Nanotechnology Applications in Transplantation Medicine. Transplantation. 2020 04; 104(4):682-693.

View in: PubMed
Kollar B, Rizzo NM, Borges TJ, Haug V, Abdulrazzak O, Kauke M, Safi AF, Lian CG, Marty FM, Rutherford AE, Mitchell RN, Murphy GF, Tullius SG, Riella LV, Pomahac B. Accelerated chronic skin changes without allograft vasculopathy: A 10-year outcome report after face transplantation. Surgery. 2020 06; 167(6):991-998.

View in: PubMed

People

Explore

Similar Concepts

Top Journals